CTT Pharmaceutical Holdings, Inc. (OTCPK: CTTH)
Health Care · Pharmaceuticals · US
$0.06
+2.91% today · -5.7% 1Y
CTT Pharmaceutical Holdings, Inc. (OTCPK: CTTH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.38M and employs 1 people.
Over the last twelve months the share price has lost 5.7%, trading between 0.04 and 0.10.
Tweenvest scores CTT Pharmaceutical Holdings, Inc. across four factors: quality 22/100, value 69/100. Its strongest factor is value.
CTTH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.38M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- $0.10
- 52-week low
- $0.04
- Avg volume (3M)
- —
- Shares outstanding
- 59.72M
- Employees
- 1
- Next earnings
- —
About CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
- ISIN
- US12651E1064
- Listed since
- Apr 18, 1997
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Addex Therapeutics LtdSWX: ADXN | $3.56M | CHF0.02 | +4.50% |
| JFL Life Sciences LimitedNSEI: JFLLIFE | $3.50M | Rs10.25 | +2.50% |
| Panjon LimitedBSE: 526345 | $3.41M | Rs19.24 | -11.62% |
| 60 Degrees Pharmaceuticals, Inc.NasdaqCM: SXTP | $3.40M | $0.97 | -30.55% |
| ODI Pharma AB (publ)NGM: ODI | $3.32M | Skr1.81 | -7.18% |
| Sanai Health Industry Group Company LimitedSEHK: 1889 | $3.31M | HK$0.17 | -10.99% |
| RedHill Biopharma Ltd.NasdaqCM: RDHL | $3.28M | $0.54 | +7.80% |
| Cadrenal Therapeutics, Inc.NasdaqCM: CVKD | $3.25M | $0.91 | -2.10% |
Figures last refreshed Oct 11, 2026.